"The United States Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) for the company's Jeedimetla facility located at Hyderabad, Telangana, India," Granules said in a BSE filing.
The company said this facility was inspected by the USFDA in March 2018 and there was one observation during the inspection. Granules said it has responded to the observation within the stipulated time frame.
The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection.
The company's shares were trading 0.16 per cent higher at Rs 94.80 on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)